Heather Turner
Nurse Practitioner · New Castle, INNPI 1710271606
Payments from drug & device makers
Across 159 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$893
- AbbVie$693
- GSK$257
- Lilly USA, LLC$253
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$215
- Novo Nordisk$200
- plus $921 from 18 others
What the payments were for
- Food & beverage$3,431100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $893 |
| AbbVie | 32 | $693 |
| GSK | 15 | $257 |
| Lilly USA, LLC | 14 | $253 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $215 |
| Novo Nordisk | 11 | $200 |
| Johnson & Johnson | 2 | $126 |
| Bayer | 8 | $125 |
| Exact Sciences | 7 | $123 |
| Phathom Pharmaceuticals, Inc. | 1 | $88 |
| Corium, LLC | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Sanofi-aventis U.S. LLC | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Amgen | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Halozyme Inc | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,431 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 59 | $82,993 |
| OzempicSemaglutide | 71 | $75,517 |
| FarxigaDapagliflozin Propanediol | 59 | $63,298 |
| JardianceEmpagliflozin | 51 | $53,896 |
| TrulicityDulaglutide | 34 | $44,814 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $35,926 |
| RybelsusSemaglutide | 31 | $35,182 |
| XareltoRivaroxaban | 28 | $25,963 |
| GemtesaVibegron | 20 | $25,037 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $20,860 |
| MyrbetriqMirabegron | 20 | $17,017 |
| VraylarCariprazine Hcl | 12 | $16,819 |
| EliquisApixaban | 19 | $13,312 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $11,528 |
| JanuviaSitagliptin Phosphate | 21 | $11,316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $253 | $127,80793 claims |
| Novo NordiskOzempic, Rybelsus | $200 | $110,700102 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $893 | $87,025101 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $257 | $44,22860 claims |
| Johnson & JohnsonXarelto | $126 | $25,96328 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $41 | $25,03720 claims |
| Astellas Pharma US IncMyrbetriq | $14 | $17,01720 claims |
| AbbVieVraylar | $693 | $16,81912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in New Castle
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.